Prevalence of four subtypes of mild cognitive impairment and APOE in a Japanese community
✍ Scribed by Megumi Sasaki; Chiine Kodama; Shin Hidaka; Fumio Yamashita; Toru Kinoshita; Kiyotaka Nemoto; Chiaki Ikejima; Takashi Asada
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 107 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.2234
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background
The results of previous reports estimating the prevalence of mild cognitive impairment (MCI) have varied widely according to the criteria used to define MCI.
Methods
We assessed the cognitive function of Japanese community‐dwelling individuals ≥65 years old and attempted to estimate the prevalence of four MCI subtypes (amnestic single, amnestic multiple, nonamnestic single, and nonamnestic multiple) using two cutoffs (1 and 1.5 SD) below normative standard. Presence of apolipoprotein E4 allele (APOE4), which is known as a strong risk factor for AD, is reportedly associated with high risk of conversion from MCI to AD. We therefore calculated the frequency of APOE4 carriers for each MCI subtype.
Results
Initially 1888 (70%) of 2698 baseline samples participated, and 1433 (53%) subjects who had complete clinical data including APOE typing remained for the final analysis. The prevalence of MCI subtypes varied within the range of 1.7–16.6%, depending on the criteria applied. Prevalence of MCI was higher using a cutoff at −1.0 SD than at −1.5 SD, and prevalence of amnestic MCI single at −1.5 SD was lowest among all subtypes of MCI. Frequency of APOE4 was higher for amnestic MCI than for non‐amnestic MCI or the cognitively normal group.
Conclusion
The prevalence of MCI was highly dependent on the diagnostic criteria applied. A higher frequency of APOE4 in participants with amnestic MCI subtype suggested a greater risk of future AD. For future interventions to delay the onset of dementia, targeting individuals with amnestic MCI multiple at −1 SD might be desirable. Copyright © 2009 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract ## Background Mild cognitive impairment (MCI) is defined to diagnose prodromal dementia and prodromal Alzheimer dementia, in particular. ## Objective The main aim of this study is to identify subtypes of MCI in comparison to the frequency of Petersen's MCI‐amnestic in an elderly age‐
## Abstract The aim of this study was to establish the rate of progression from mild cognitive impairment (MCI) to dementia in patients with Parkinson's disease (PD). PD patients without dementia were recruited in 1997 from an ongoing prospective epidemiological study. The assessment included neuro
## Background The aim of the study was to estimate the prevalence of __DSM‐III‐R__ major depressive episodes (MDEs), depressive symptoms cases (DSCs) (defined as a score of ≥6 on the Geriatric Depression Scale but falling short of MDE), and coexisting mild cognitive impairment (MCI) among Japanese
## Abstract ## Objective This study aimed at estimating the prevalence of cognitive and functional impairment (CFI) in a community sample in Ribeirão Preto, Brazil, evaluating its distribution in relation to various socio‐demographic and clinical factors. ## Methods The population was a represen
Dementia has been a major public health problem and mild cognitive impairment is considered the pre-dementia syndrome in recent years. However, there has not yet been a systematic analysis of the prevalence of mild cognitive impairment in China. Objectives: The aim of this study was to analyse the